Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis

Kyung Ho Choi, Bong Lee Eun, Dal Yoo Chang, Joo Baek Han, Wook Kang Seong, Chul Shin Ki, Jong Lee Yun, Ah Kim Hyun, Ju Hong Jeon, Chai Wan Kim, Dong Myung Shin, In Gyu Kim, Wook Song Yeong

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Filaggrin is expressed in the cornified layer of epidermis and known to be one of the antigenic targets in rheumatoid arthritis. Although the citrulline residue in filaggrin is thought to be an antigenic determinant recognized by autoantibodies, the diagnostic sensitivity of synthetic citrullinated peptide is variable. To investigate the implication of anti-filaggrin antibodies recognizing uncitrullinated filaggrin in rheumatoid arthritis, we assayed antibody titers using unmodified recombinant filaggrin in the sera from 73 patients with rheumatoid arthritis, 150 patients with other connective tissue diseases and 70 normal controls. We also performed the correlation analysis between antibody titers and the clinical variables in patients with rheumatoid arthritis. Titers of IgG anti-filaggrin antibodies were significantly higher in rheumatoid arthritis patients compared to normal controls (P = 0.02), but not in patients with osteoarthritis, ankylosing spondylitis or systemic lupus erythematosus. IgG anti-filaggrin antibodies were more frequently found in patients with rheumatoid arthritis compared to normal controls (12.3% vs 1.4% respectively, P = 0.04). An anti-filaggrin antibody titer was correlated with visual analogue scale of pain, tender joint count, Ritchie articular index or C-reactive protein, but not with anti-nuclear antibody or rheumatoid factor. These results suggest that anti-filaggrin antibody recognizes the uncitrullinated filaggrin as an antigen and its titer correlates with clinical parameters, explaining the variable sensitivity of anti-filaggrin antibody test.

Original languageEnglish (US)
Pages (from-to)546-552
Number of pages7
JournalExperimental and Molecular Medicine
Volume37
Issue number6
DOIs
StatePublished - Dec 31 2005

Keywords

  • Autoimmune
  • Cyclin citrullinated peptide
  • Diseases
  • Filaggrin
  • Immunoenzyme techniques
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis'. Together they form a unique fingerprint.

  • Cite this

    Choi, K. H., Eun, B. L., Chang, D. Y., Han, J. B., Seong, W. K., Ki, C. S., Yun, J. L., Hyun, A. K., Jeon, J. H., Kim, C. W., Shin, D. M., Kim, I. G., & Yeong, W. S. (2005). Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis. Experimental and Molecular Medicine, 37(6), 546-552. https://doi.org/10.1038/emm.2005.67